Wingstop Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Wingstop Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $696.85M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $625.81M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $460.06M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $357.52M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $282.50M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $248.81M | Feb 22, 2023 |
| FY2019 | Dec 28, 2019 | $53.19M | Feb 19, 2020 |
| FY2019 | Sep 28, 2019 | $49.88M | Feb 19, 2020 |
| FY2019 | Jun 29, 2019 | $48.56M | Feb 19, 2020 |
| FY2019 | Mar 30, 2019 | $48.05M | Feb 19, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 30, 2017 | $28.29M | Feb 23, 2018 |
| FY2017 | Sep 30, 2017 | $26.03M | Feb 23, 2018 |
| FY2017 | Jul 1, 2017 | $24.67M | Feb 23, 2018 |
| FY2017 | Apr 1, 2017 | $26.57M | Feb 23, 2018 |
| FY2017 | Dec 31, 2016 | $24.75M | Feb 23, 2018 |
| FY2017 | Sep 24, 2016 | $21.81M | Feb 23, 2018 |
| FY2017 | Jun 25, 2016 | $22.72M | Feb 23, 2018 |
| FY2017 | Mar 26, 2016 | $22.07M | Feb 23, 2018 |
| FY2016 | Dec 26, 2015 | $20.58M | Mar 3, 2017 |
| FY2016 | Sep 26, 2015 | $19.13M | Mar 3, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $174.27M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $108.72M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $70.18M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $52.95M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $42.66M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $23.31M | Feb 22, 2023 |
| FY2019 | Dec 28, 2019 | $3.05M | Feb 19, 2020 |
| FY2019 | Sep 28, 2019 | $5.91M | Feb 19, 2020 |
| FY2019 | Jun 29, 2019 | $4.92M | Feb 19, 2020 |
| FY2019 | Mar 30, 2019 | $6.61M | Feb 19, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $179.29M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $165.62M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $112.59M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $91.93M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $73.76M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $57.39M | Feb 22, 2023 |
| FY2019 | Dec 28, 2019 | $8.89M | Feb 19, 2020 |
| FY2019 | Sep 28, 2019 | $11.95M | Feb 19, 2020 |
| FY2019 | Jun 29, 2019 | $10.29M | Feb 19, 2020 |
| FY2019 | Mar 30, 2019 | $11.77M | Feb 19, 2020 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $128.36M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $116.80M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $96.90M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $67.06M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $62.90M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $61.08M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $50.18M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $44.58M | Feb 18, 2021 |
| FY2019 | Dec 30, 2017 | $34.90M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $34.55M | Feb 27, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $153.07M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $157.61M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $121.60M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $76.24M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $48.88M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $65.53M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $38.58M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $38.77M | Feb 18, 2021 |
| FY2019 | Dec 30, 2017 | $27.44M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $21.88M | Feb 27, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $47.44M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $51.93M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $40.83M | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | $23.94M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $28.02M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $6.05M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $22.49M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $3.98M | Feb 18, 2021 |
| FY2019 | Dec 30, 2017 | $2.54M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $2.06M | Feb 27, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $693.41M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $716.25M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $377.83M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $424.19M | Feb 21, 2024 |
| FY2022 | Dec 25, 2021 | $249.20M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $211.57M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $166.11M | Feb 18, 2021 |
| FY2019 | Dec 29, 2018 | $139.75M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $119.84M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $111.80M | Feb 23, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $1.43B | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $1.39B | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $835.19M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $815.05M | Feb 21, 2024 |
| FY2022 | Dec 25, 2021 | $558.73M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $552.88M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $375.54M | Feb 18, 2021 |
| FY2019 | Dec 29, 2018 | $364.58M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $178.25M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $186.43M | Feb 23, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($736.76M) | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | ($675.59M) | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | ($457.37M) | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | ($390.86M) | Feb 19, 2025 |
| FY2025 | Dec 26, 2022 | ($390.86M) | Feb 18, 2026 |
| FY2024 | Dec 25, 2021 | ($309.53M) | Feb 19, 2025 |
| FY2023 | Dec 26, 2020 | ($341.31M) | Feb 21, 2024 |
| FY2022 | Dec 28, 2019 | ($209.43M) | Feb 22, 2023 |
| FY2021 | Dec 29, 2018 | ($224.83M) | Feb 16, 2022 |
| FY2020 | Dec 30, 2017 | ($58.42M) | Feb 18, 2021 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $83.88M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $74.72M | Feb 18, 2026 |
| FY2025 | Dec 30, 2023 | $67.71M | Feb 18, 2026 |
| FY2024 | Dec 31, 2022 | $62.51M | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | $56.88M | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | $53.69M | Feb 22, 2023 |
| FY2021 | Dec 28, 2019 | $50.19M | Feb 16, 2022 |
| FY2019 | Aug 22, 2019 | $533.0K | Feb 19, 2020 |
| FY2020 | Dec 29, 2018 | $49.66M | Feb 18, 2021 |
| FY2019 | May 1, 2018 | $1.31M | Feb 19, 2020 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | ($744.92M) | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | ($676.94M) | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | ($459.99M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($393.32M) | Feb 21, 2024 |
| FY2022 | Dec 25, 2021 | ($310.03M) | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | ($342.03M) | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | ($210.28M) | Feb 18, 2021 |
| FY2019 | Dec 29, 2018 | ($226.16M) | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | ($58.97M) | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | ($76.11M) | Feb 23, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $196.57M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | $315.91M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | $90.22M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $184.50M | Feb 21, 2024 |
| FY2022 | Dec 25, 2021 | $48.58M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | $40.86M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $12.85M | Feb 18, 2021 |
| FY2019 | Dec 29, 2018 | $12.49M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $4.06M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | $3.75M | Feb 23, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | $1.22B | Feb 18, 2026 |
| FY2024 | Dec 28, 2024 | $1.22B | Feb 19, 2025 |
| FY2023 | Dec 30, 2023 | $720.93M | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $724.58M | Feb 22, 2023 |
| FY2021 | Dec 25, 2021 | $477.60M | Feb 16, 2022 |
| FY2020 | Dec 26, 2020 | $480.00M | Feb 18, 2021 |
| FY2019 | Dec 28, 2019 | $317.60M | Feb 19, 2020 |
| FY2018 | Dec 29, 2018 | $320.00M | Feb 27, 2019 |
| FY2017 | Dec 30, 2017 | $133.75M | Feb 23, 2018 |
| FY2016 | Dec 31, 2016 | $151.25M | Mar 3, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 6 | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 3 | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | 2 | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | 0 | Feb 22, 2023 |
| FY2019 | Dec 28, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 28, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 29, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 30, 2019 | 0 | Feb 19, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 6 | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 3 | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | 2 | Feb 19, 2025 |
| FY2024 | Dec 31, 2022 | 1 | Feb 19, 2025 |
| FY2023 | Dec 25, 2021 | 1 | Feb 21, 2024 |
| FY2022 | Dec 26, 2020 | 0 | Feb 22, 2023 |
| FY2019 | Dec 28, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Sep 28, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Jun 29, 2019 | 0 | Feb 19, 2020 |
| FY2019 | Mar 30, 2019 | 0 | Feb 19, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 27, 2025 | 27.54M | Feb 18, 2026 |
| FY2025 | Dec 28, 2024 | 28.66M | Feb 18, 2026 |
| FY2024 | Dec 30, 2023 | 29.34M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 29.93M | Feb 21, 2024 |
| FY2022 | Dec 25, 2021 | 29.84M | Feb 22, 2023 |
| FY2021 | Dec 26, 2020 | 29.69M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | 29.46M | Feb 18, 2021 |
| FY2019 | Dec 29, 2018 | 29.30M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | 29.09M | Feb 27, 2019 |
| FY2017 | Dec 31, 2016 | 28.75M | Feb 23, 2018 |